ADMA Biologics, Inc. (ADMA)
10.08
-0.17
(-1.66%)
USD |
NASDAQ |
May 06, 16:00
8.07
-2.01
(-19.94%)
After-Hours: 07:05
ADMA Biologics Free Cash Flow : 27.50M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Inovio Pharmaceuticals, Inc. | -88.92M |
| ANI Pharmaceuticals, Inc. | 150.90M |
| Liquidia Corp. | -40.02M |
| Ligand Pharmaceuticals, Inc. | 38.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 35.64M |
| Cash from Investing (Quarterly) | -0.276M |
| Cash from Financing (Quarterly) | -9.118M |
| Free Cash Flow Per Share (Quarterly) | 0.1409 |
| Free Cash Flow to Equity (Quarterly) | 37.60M |
| Free Cash Flow to Firm (Quarterly) | 35.67M |
| Free Cash Flow Yield | 1.11% |